TOME BIOSCIENCES
Tome Biosciences, Inc., is the programmable genomic integration (PGI) company. Tome's technologies allow it to insert any genetic sequence of any size at any location in the genome with site-specific precision. The Company is writing the final chapter in genomic medicines, delivering cures to patients through cell and integrative gene therapies.
Disclaimer : All logos and trademarks on this website are the property of their respective owners. The information on this website is not a medical or investment related advice. The information about the company might not reflect the most current or accurate information. Please refer to the company's respective website for the most accurate information.